Related Experiment Videos
Immunologic abnormalities in patients with hemophilia A
The Journal of Pediatrics
|November 1, 1983
Summary
Healthy individuals with hemophilia A may show early signs of immunodeficiency. Studies revealed decreased T cell ratios and impaired immune responses in patients treated with factor VIII concentrate or cryoprecipitate.
Area of Science:
- Immunology
- Hematology
Background:
- Hemophilia A is a genetic bleeding disorder.
- Treatment involves blood clotting factors.
- Immunologic status in treated patients requires assessment.
Purpose of the Study:
- To evaluate T cell immunity in healthy individuals with hemophilia A.
- To compare immune responses between different treatment groups.
Main Methods:
- Studied T cell immunity in 21 hemophilia A patients.
- Compared patients receiving cryoprecipitate versus factor VIII concentrate.
- Assessed T cell ratios, mononuclear cell response to phytohemagglutinin, and mixed lymphocyte culture.
Main Results:
- Factor VIII concentrate group showed decreased helper/suppressor T cell ratios.
- Both patient groups exhibited diminished mononuclear cell response to phytohemagglutinin.
- No correlation found between immune abnormalities and viral antibodies (CMV, EBV, Hepatitis B).
Conclusions:
- Asymptomatic individuals with hemophilia A can exhibit early immunodeficiency.
- Treatment modalities may influence T cell immunity.
- Physicians should monitor immune status in hemophilia A patients.